This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Abstract Details

Activity Number: 394
Type: Topic Contributed
Date/Time: Tuesday, August 3, 2010 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #307752
Title: Strategies for Global Drug Development: Bridging vs. Multiregional Clinical Trials
Author(s): William Wang*+ and William Malbecq
Companies: Merck & Co., Inc. and Merck & Co., Inc.
Address: 28 Floor, Park Place, Shanghai, 200040, China
Keywords: Bridging ; MRCT ; Regional Consistency
Abstract:

In recent years, there has been an increasing trend by multinational companies to perform global clinical trials in emerging market regions. This presentation will feature the current state of clinical trials in Asia Pacific region. We will discuss some region-specific statistical considerations such as sample size requirements, statistical significance and regional consistency. We will also discuss the pros and cons of two different types of strategies: those using bridging trials versus those using multi-regional clinical trials (MRCTs). Simulations will be used to evaluate these strategies.


The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2010 program




2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.